Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer (Q74250079)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1998

Language	Label	Description	Also known as
English	Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer	scientific article published on 01 January 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9484667%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

J T Wu

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

G H Liu

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9484667%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Journal of Clinical Laboratory Analysis

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

32-40

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

Assay for prostate specific antigen (PSA): problems and possible solutions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Evaluation of free PSA isoforms, PSA complex formation, and specificity of anti-PSA antibodies by HPLC and PAGE-immunoblotting techniques

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Prostate-specific antigen and prostate gland volume: Correlation and clinical application

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Correlation of serum concentrations of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281998%2912%3A1%3C32%3A%3AAID-JCLA6%3E3.0.CO%3B2-L

21 January 2018

Development of an immunoassay specific for the PSA-ACT complex without the problem of high background

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large discrepancy between prostate-specific antigen results from different assays during longitudinal follow-up of a prostate cancer patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum prostate-specific antigen assay--an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9484667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/(SICI)1098-2825(1998)12:1<32::AID-JCLA6>3.0.CO;2-L

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6807798&resulttype=core&format=json

12 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74250079&oldid=2034301170"